CSBR - Financial Reports List - Champions Oncology, Inc. - IntrinsicAlpha

Champions Oncology, Inc. CSBR

Healthcare - Biotechnology - NASDAQ - US

$ 7.97

-0.627 %

$ 110 M

Market Cap

17.6

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q3	8-K	2025-01-31	41.77%	277.67%	274.58%
Quarterly Report	Q2	8-K	2024-10-31	16.56%	135.15%	137.44%
Quarterly Report	Q1	8-K	2024-07-31	11.94%	151.17%	152.08%
Quarterly Report	Q4	8-K	2024-04-30	7.11%	95.74%	109.57%
Annual Report	FY	10-K	2024-04-30	-6.90%	-36.38%	-65.34%
Quarterly Report	Q3	8-K	2024-01-31	-5.90%	-3.73%	-4.84%
Quarterly Report	Q2	8-K	2023-10-31	-18.96%	-12843.75%	-27928.57%
Quarterly Report	Q1	8-K	2023-07-31	-8.61%	-704.39%	-798.59%
Quarterly Report	Q4	8-K	2023-04-30	1.51%	-644.48%	-451.13%
Annual Report	FY	10-K	2023-04-30	9.69%	-973.54%	-732.95%

1